Comparison of diagnostic performances of different serological tests for SARS-CoV-2 antibody detection in cats and dogs

被引:5
|
作者
Ratti, Gabriele [1 ]
Lelli, Davide [2 ]
Moreno, Ana [2 ]
Stranieri, Angelica [1 ]
Trogu, Tiziana [2 ]
Giordano, Alessia [1 ]
Grassi, Andrea [3 ]
Luzzago, Camilla [1 ]
Decaro, Nicola [4 ]
Paltrinieri, Saverio [1 ]
Lauzi, Stefania [1 ]
机构
[1] Univ Milan, Dept Vet Med & Anim Sci, Lodi, Italy
[2] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Dept Virol, Brescia, Italy
[3] I VET Srl, Lab Anal Vet, Brescia, Italy
[4] Univ Bari Aldo Moro, Dept Vet Med, Bari, Italy
关键词
cats; diagnostic tests accuracy; dogs; immunological assay; serosurveillance; severe acute respiratory coronavirus 2; CORONAVIRUS;
D O I
10.1111/tbed.14716
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Serosurveillance among animals, including pets, plays an important role in the current coronavirus disease 2019 (COVID-19) pandemic, because severe acute respiratory coronavirus 2 (SARS-CoV-2) infections in animal populations could result in the establishment of new virus reservoirs. Serological assays that offer the required sensitivity and specificity are essential. In this study, we evaluated the diagnostic performance of three different commercially available immunoassays for the detection of SARS-CoV-2 antibodies in pets, namely two ELISA tests for the detection of antibodies against SARS-CoV-2 nucleocapsid [ID Screen SARS CoV-2 double antigen multispecies (Double antigen) and ID Screen (R) SARS-CoV-2-N IgG indirect ELISA (Indirect)] and one test for the detection of neutralizing antibodies against SARS-CoV-2 receptor-binding-domain [surrogate virus neutralization test (sVNT)]. The obtained results were compared with those of conventional virus neutralization test (VNT), which was regarded as reference method. A total of 191 serum samples were analysed. Thirteen (6.8%) samples showed VNT-positive results. The overall sensitivity was higher for sVNT (100%) compared to nucleocapsid-based ELISA assays (23% for Double antigen and 60% for Indirect). The specificity was 100% for Indirect ELISA and sVNT, when a higher cut-off (>30%) was used compared to the one previously defined by the manufacturer (>20%), whereas the other test showed lower value (99%). The sVNT test showed the highest accuracy and agreement with VNT, with a perfect agreement when the higher cut-off was applied. The agreement between each nucleocapsid-based ELISA test and VNT was 96% for Indirect and 94% for Double antigen. Our findings showed that some commercially available serological tests may lead to a high rate of false-negative results, highlighting the importance of assays validation for the detection of SARS-CoV-2 antibodies in domestic animals.
引用
收藏
页码:3530 / 3539
页数:10
相关论文
共 50 条
  • [41] Interpretation of diagnostic tests for the SARS-Cov-2 virus
    Virginia Diaz-Jimenez, Irma
    ACTA PEDIATRICA DE MEXICO, 2020, 41 (04): : S51 - S57
  • [42] Frequency of SARS-CoV-2 infection in dogs and cats: Results of a retrospective serological survey in Sumadija District, Serbia
    Stanojevic, Slavoljub
    Radojicic, Sonja
    Misic, Dusan
    Srejic, Damjan
    Vasiljevic, Dragan V.
    Prokic, Kristina
    Ilic, Nevenka
    PREVENTIVE VETERINARY MEDICINE, 2022, 208
  • [43] Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan
    Chao, Chiao-Hsuan
    Cheng, Dayna
    Huang, Sheng-Wen
    Chuang, Yung-Chun
    Yeh, Trai-Ming
    Wang, Jen-Ren
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [44] Exploratory assessment of serological tests to determine antibody titer against SARS-CoV-2: Appropriateness and limits
    Colombini, Alessandra
    Vigano, Marco
    Tomaiuolo, Rossella
    Resta, Chiara
    Corea, Francesca
    Sabetta, Eleonora
    Ferrari, Davide
    De Vecchi, Elena
    Spano, Sestina Maria
    Banfi, Giuseppe
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (05)
  • [45] Longitudinal evaluation of laboratory-based serological assays for SARS-CoV-2 antibody detection
    Bond, K. A.
    Williams, E.
    Nicholson, S.
    Lim, S.
    Johnson, D.
    Cox, B.
    Putland, M.
    Gardiner, E.
    Tippett, E.
    Graham, M.
    Mordant, F.
    Catton, M.
    Lewin, S. R.
    Subbarao, K.
    Howden, B. P.
    Williamson, D. A.
    PATHOLOGY, 2021, 53 (06) : 773 - 779
  • [46] Fusing Peptide Epitopes for Advanced Multiplex Serological Testing for SARS-CoV-2 Antibody Detection
    Aldoukhi, Ali H.
    Bilalis, Panayiotis
    Alhattab, Dana M.
    Valle-Perez, Alexander U.
    Susapto, Hepi H.
    Perez-Pedroza, Rosario
    Backhoff-Garcia, Emiliano
    Alsawaf, Sarah M.
    Alshehri, Salwa
    Boshah, Hattan
    Alrashoudi, Abdulelah A.
    Aljabr, Waleed A.
    Alaamery, Manal
    Alrashed, May
    Hasanato, Rana M.
    Farzan, Raed A.
    Alsubki, Roua A.
    Moretti, Manola
    Abedalthagafi, Malak S.
    Hauser, Charlotte A. E.
    ACS BIO & MED CHEM AU, 2023, 4 (01): : 37 - 52
  • [47] Comparison of various serological assays for novel SARS-COV-2
    María Simón Sacristan
    Ana Collazos-Blanco
    Maria Isabel Zamora Cintas
    Alicia Serrano García
    Carmen Ybarra de Villavicencio
    María Mateo Maestre
    European Journal of Clinical Microbiology & Infectious Diseases, 2021, 40 : 963 - 968
  • [48] Evaluation of the Diagnostic Performance of Different Principles of SARS-CoV-2 Commercial Antibody Tests in COVID-19 Patients
    Dinc, Harika Oyku
    Ozdemir, Yusuf Emre
    Alkan, Sena
    Dalar, Zeynep Gungordu
    Gareayaghi, Nesrin
    Sirekbasan, Serhat
    Tok, Yesim Tuyji
    Kuskucu, Mert Ahmet
    Karaali, Ridvan
    Ozbey, Dogukan
    Aygun, Gokhan
    Midilli, Kenan
    Kocazeybek, Bekir
    MIKROBIYOLOJI BULTENI, 2021, 55 (02): : 207 - 222
  • [49] Comparison and application of different immunoassay methods for the detection of SARS-CoV-2
    He, Jingyun
    Hu, Peng
    Gao, Yu
    Zheng, Shengwei
    Xu, Chao
    Liu, Rongzhi
    Fang, Li
    Li, Ran
    Han, Congyin
    An, Juanjuan
    Dong, Jinchun
    Deng, Gang
    Sun, Lei
    Lv, Yunfeng
    JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (11) : 2777 - 2784
  • [50] Evaluating a SARS-CoV-2 screening strategy based on serological tests
    Baccini, Michela
    Mattei, Alessandra
    Rocco, Emilio
    Vannucci, Giulia
    Mealli, Fabrizia
    EPIDEMIOLOGIA & PREVENZIONE, 2020, 44 (5-6): : 193 - 199